PHARMARESEARCH BIO Co., Ltd. (XKON:217950)

South Korea flag South Korea · Delayed Price · Currency is KRW
34,200
0.00 (0.00%)
At close: Feb 19, 2026
Market Cap145.70B +26.8%
Revenue (ttm)178.19M -44.5%
Net Income-883.52M
EPS-22,088.06
Shares Out4.18M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,371
Average Volume2,342
Open34,650
Previous Closen/a
Day's Range33,800 - 34,850
52-Week Range25,000 - 50,000
Beta0.53
RSI46.79
Earnings Daten/a

About PHARMARESEARCH BIO

PharmaResearch BIO Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products worldwide. The company offers ReNTox injection for temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged between 18 and 65. It is also developing Clostridium Botulinum Toxin type A, which is in Phase I clinical study for indications, including dynamic equinus foot deformity, upper limb spasticity, blepharospasm, etc. The co... [Read more]

Industry Pharmaceutical Preparations
Founded 2009
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 217950
Full Company Profile

Financial Performance

Financial Statements